UPPSALA, SWEDEN – LIDDS AB (publ) announces today that the company will participate in two important events this spring. Firstly, the BIO-Europe Spring meeting, taking place in Basel between 20 and 22 March 2023. Secondly, the EACR Defence is the Best Attack: Immuno-Oncology Breakthroughs conference, taking place in Barcelona between 9 and 11 May 2023.
LIDDS’ CEO Anders Månsson will participate in the BIO-Europe Spring meeting, which is physically organized in Basel, Switzerland. BIO-Europe is the premier European partnering event and provides LIDDS with opportunities for both collaboration and partner discussions as well as investor meetings. LIDDS’ attendance will be in conjunction with our partnership with Alira Health to drive forward our on-going business development activities.
LIDDS’ Head of Preclinical, Erwin Brenndörfer will attend the European Association for Cancer Research (EACR) meeting titled “Defence is the Best Attack: Immuno-Oncology Breakthroughs” after submitting an abstract on LIDDS’ Nanoimod project, and successfully being accepted to deliver a poster presentation. Erwin will share more details on the strong progress with this project as LIDDS prepares for a possible Phase I initiation this year.